Glanzmann thrombasthenia in pregnancy: Optimising maternal and fetal outcomes

Obstetric Medicine

Volumn 9, Issue 4, 2016, Pages 169-170

  Wijemanne, A ^a   Watt Coote, I ^a   Austin, S ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Glanzmann thrombasthenia; haematology; haemorrhage; High risk pregnancy; maternal fetal medicine; neonatal alloimmune thrombocytopenia

Indexed keywords

GLYCOPROTEIN IIIA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STEROID; THROMBOCYTE ANTIGEN; TRANEXAMIC ACID;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CASE REPORT; FEMALE; FETUS OUTCOME; GLANZMANN DISEASE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MISSENSE MUTATION; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; PLASMAPHERESIS; POSTPARTUM HEMORRHAGE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIMIGRAVIDA; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION;

EID: 84994010355     PISSN: 1753495X     EISSN: 17534968     Source Type: Journal    
DOI: 10.1177/1753495X16655021     Document Type: Article

References (14)

1. Dunsmore K. Intravenous immunoglobulin G therapy in fetal and neonatal alloimmune thrombocytopenia. BioDrugs 1997; 8: 265–272.
2. Nurden A. Glanzmann’s thrombasthenia. Orphanet J Rare Dis 2006; 1: 10–10.
3. Madgudapathi C, Kannan S, Giri D. Glanzmann’s thrombasthenia complicating pregnancy. J Clin Case Rep 2012; 2: 142–142.
4. Sebastiano C, Bromberg M, Breen K, Hurford MT. Glanzmann’s thrombasthenia: report of a case and review of the literature. Int J Clin Exp Pathol 2010; 3: 443–447.
5. George JN, Caen JP, Nurden AT. Glanzmann’s thrombasthenia: the spectrum of clinical disease. Blood 1990; 75: 1383–1395.
6. Malhotra N. Pregnancy in a patient of Glanzmanns Thombasthenia. Indian J Med Sci 2006; 60: 3–3.
7. Laursen B, Jacobsen S. Transfusion problems in patients with Glanzmann’s thrombasthenia. Eur J Haematol 1992; 49: 143–144.
8. Lethagen S, Nilson IM. DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand Factor and the platelet receptor GPIIb/IIIa. Eur J Haematol 1992; 42: 7–13.
9. Kale A, Bayhan G, Yalinkaya A. The use of recombinant factor VIIa in a primigravida with Glanzmann’s thrombasthenia during delivery. J Perinat Med 2004; 32: 456–458.
10. Nurden AT, Pillois X, Wilcox DA. Glanzmann thrombasthenia: state of the art and future directions. Semin Thromb Hemost 2013; 39: 642–655.
11. Siddiq S, Clark A, Mumford A. A systematic review of the management and outcomes of pregnancy in Glanzmann’s thrombasthenia. Haemophilia 2011; 17: e858–e869.
12. Sherer DM, Lerner R. Glanzmann’s thrombasthenia in pregnancy: a case and review of the literature. Am J Perinatol 1999; 16: 297–301.
13. Shamsi TS, Hossain N, Soomro N. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature. J Pak Med Assoc 2005; 55: 512–515.
14. Leticee N, Kaplan C, Lemery D. Pregnancy in mother with Glanzmann’s thrombasthenia and isoantibody against GPIIb-IIIa: is there a foetal risk? Euro J Obstet Gynecol Reprod Bio 2005; 121: 139–142.